Former Portfolio Companies

CytomX Therapeutics is a clinical-stage biopharmaceutical company with a deep and differentiated oncology pipeline of investigational Probody therapeutics.

IPO in 2015 (TK: CTMX) South San Francisco, CA visit www.cytomx.com